NASDAQ:INGN Inogen (INGN) Stock Price, News & Analysis $6.80 +0.07 (+1.04%) Closing price 07/24/2025 04:00 PM EasternExtended Trading$6.86 +0.06 (+0.94%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Inogen Stock (NASDAQ:INGN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Inogen alerts:Sign Up Key Stats Today's Range$6.56▼$6.8750-Day Range$5.96▼$7.5052-Week Range$5.70▼$13.33Volume215,952 shsAverage Volume170,577 shsMarket Capitalization$182.85 millionP/E RatioN/ADividend YieldN/APrice Target$11.00Consensus RatingModerate Buy Company Overview Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. Read More Inogen Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks85th Percentile Overall ScoreINGN MarketRank™: Inogen scored higher than 85% of companies evaluated by MarketBeat, and ranked 150th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingInogen has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageInogen has only been the subject of 3 research reports in the past 90 days.Read more about Inogen's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Inogen are expected to grow in the coming year, from ($1.73) to ($1.48) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inogen is -5.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inogen is -5.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInogen has a P/B Ratio of 0.93. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Inogen's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.81% of the float of Inogen has been sold short.Short Interest Ratio / Days to CoverInogen has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in Inogen has recently decreased by 6.48%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInogen does not currently pay a dividend.Dividend GrowthInogen does not have a long track record of dividend growth. Sustainability and ESG3.9 / 5Environmental Score-1.12 Percentage of Shares Shorted3.81% of the float of Inogen has been sold short.Short Interest Ratio / Days to CoverInogen has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in Inogen has recently decreased by 6.48%, indicating that investor sentiment is improving significantly. News and Social Media1.4 / 5News Sentiment0.50 News SentimentInogen has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Inogen this week, compared to 3 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Inogen insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.46% of the stock of Inogen is held by insiders.Percentage Held by Institutions89.94% of the stock of Inogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inogen's insider trading history. Receive INGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter. Email Address INGN Stock News HeadlinesInogen: Earnings Uncertainty Weakens Valuation Argument (Rating Downgrade)July 21, 2025 | seekingalpha.comInogen to Report Second Quarter 2025 Financial Results on August 7, 2025July 17, 2025 | businesswire.comThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime. | Brownstone Research (Ad)Inogen, Inc. (INGN) Latest Stock News & Headlines - Yahoo FinanceJuly 8, 2025 | ca.finance.yahoo.comInogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen TherapyJune 23, 2025 | businesswire.comInogen (INGN) Stock Coverage Initiated by B. Riley Securities | INGN Stock NewsJune 16, 2025 | gurufocus.comInogen: Still Breathing, But Margin Pressures PersistJune 16, 2025 | seekingalpha.comInogen (INGN) Initiated with Buy Rating by B. Riley Analyst | INGN Stock NewsJune 16, 2025 | gurufocus.comSee More Headlines INGN Stock Analysis - Frequently Asked Questions How have INGN shares performed this year? Inogen's stock was trading at $9.17 at the beginning of the year. Since then, INGN stock has decreased by 25.8% and is now trading at $6.80. How were Inogen's earnings last quarter? Inogen, Inc (NASDAQ:INGN) announced its earnings results on Wednesday, May, 7th. The medical technology company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.52) by $0.27. The medical technology company earned $82.28 million during the quarter, compared to analysts' expectations of $79.57 million. Inogen had a negative net margin of 8.08% and a negative trailing twelve-month return on equity of 14.76%. Read the conference call transcript. Who are Inogen's major shareholders? Top institutional investors of Inogen include Wealth Enhancement Advisory Services LLC (0.07%). View institutional ownership trends. How do I buy shares of Inogen? Shares of INGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Inogen own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inogen investors own include American Water Works (AWK), Waste Connections (WCN), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR) and iShares Micro-Cap ETF (IWC). Company Calendar Last Earnings5/07/2025Today7/25/2025Next Earnings (Confirmed)8/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:INGN CIK1294133 Webwww.inogen.com Phone(805) 562-0500FaxN/AEmployees1,030Year Founded2001Price Target and Rating Average Price Target for Inogen$11.00 High Price Target$14.00 Low Price Target$7.00 Potential Upside/Downside+61.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($1.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$35.89 million Net Margins-8.08% Pretax Margin-8.24% Return on Equity-14.76% Return on Assets-9.01% Debt Debt-to-Equity RatioN/A Current Ratio3.07 Quick Ratio2.67 Sales & Book Value Annual Sales$335.70 million Price / Sales0.54 Cash FlowN/A Price / Cash FlowN/A Book Value$7.30 per share Price / Book0.93Miscellaneous Outstanding Shares26,890,000Free Float26,494,000Market Cap$182.85 million OptionableOptionable Beta1.66 Social Links A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:INGN) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Inogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.